Kiniksa Pharmaceuticals International, PLC (KNSA) — SC 13D/A Filings
All SC 13D/A filings from Kiniksa Pharmaceuticals International, PLC. Browse 1 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (1)
-
Baker Bros. Advisors Updates Kiniksa Pharma Stake
— Oct 8, 2024 Risk: medium
Baker Bros. Advisors LP, through its affiliates FBB3 LLC and Baker Bros. Advisors (GP) LLC, has amended its Schedule 13D filing regarding Kiniksa Pharmaceutical
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX